Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"JTO clinical and research reports"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Shiotsu%2C+Shinsuke%22&type=Person&filter%5B%5D=journalStr%3A%22JTO+clinical+and+research+reports%22
/vufind/Search/Results?lookfor=%22Shiotsu%2C+Shinsuke%22&type=Person&filter%5B%5D=journalStr%3A%22JTO+clinical+and+research+reports%22
Search /vufind/Search2/Results?lookfor=%22Shiotsu%2C+Shinsuke%22&type=Person&filter%5B%5D=journalStr%3A%22JTO+clinical+and+research+reports%22
PubPharm (6)
1
Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC : A Prospective Study
enthalten in:
JTO clinical and research reports
| 2024
von
Katayama, Y.
|
Yamada, T.
|
Morimoto, K.
| +17
Wird geladen...
2
TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma : A Prospective Observational Study
enthalten in:
JTO clinical and research reports
| 2023
von
Katayama, Y.
|
Yamada, T.
|
Morimoto, K.
| +17
Wird geladen...
3
Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy : A Prospective Observational Study
enthalten in:
JTO clinical and research reports
| 2023
von
Ishida, M.
|
Morimoto, K.
|
Yamada, T.
| +13
Wird geladen...
4
Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II) : A Single-Arm, Open-Label, Phase 2 Clinical Trial
enthalten in:
JTO clinical and research reports
| 2022
von
Hibino, M.
|
Hiranuma, O.
|
Takemura, Y.
| +17
Wird geladen...
5
A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
enthalten in:
JTO clinical and research reports
| 2022
von
Morimoto, K.
|
Sawada, R.
|
Yamada, T.
| +15
Wird geladen...
6
Efficacy and Safety of Programmed Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC : A Prospective Observational Study
enthalten in:
JTO clinical and research reports
| 2022
von
Morimoto, K.
|
Yamada, T.
|
Takeda, T.
| +13
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: JTO clinical and research reports
Medienart
6
Aufsätze
6
E-Artikel
6
E-Ressourcen
Zeitschriftentitel
JTO clinical and research reports
Thema
6
Journal Article
3
Chemoimmunotherapy
2
Non–small cell lung cancer
2
Osimertinib
2
PD-L1
1
Angiogenesis inhibitor
1
Bevacizumab
1
Cancer cachexia
1
Combined chemoimmunotherapy
1
EGFR mutation
1
EGFR tyrosine kinase inhibitors
1
Early tumor shrinkage
1
Elderly
1
Extensive-stage small-cell lung cancer
1
Extensive-stage-small cell lung cancer
1
Immune checkpoint inhibitor
1
Lung adenocarcinoma
1
Objective response
1
PD-L1 inhibitor plus platinum-etoposide chemoth...
1
Poor performance status
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
2
2023
3
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6
Englisch
Haven't found what you're looking for?
Wird geladen...